Chongqing Pharscin Pharmaceutical Co.,Ltd.’s Net Profit Dropped 20.4% in First Half of 2023

Chongqing Pharscin Pharmaceutical Co.,Ltd. (重庆华森制药股份有限公司) (002907.SZ) reported a net profit of 41.4 million yuan in the first half of 2023, down 20.4% year-on-year.

Meanwhile, the company posted 360.5 million yuan in revenue, down 2% year-on-year.

At the end of the reporting period, it had 1.9 billion yuan in total assets and 294.5 million yuan in total liabilities, with a liability-to-asset ratio of 15.3%.